跳至主要内容
临床试验/NCT06241586
NCT06241586已完成不适用

A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis: A Retrospective Cohort Study

Tianjin Nankai Hospital1 个研究点 分布在 1 个国家目标入组 271 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
271
试验地点
1
主要终点
major complications

研究概览

简要总结

The goal of this observational study is to compare patient outcomes between the groups of patients admitted before and after the full implementation of the novel surgical strategy in patients with necrotizing pancreatitis. The main question it aims to answer are:

• the efficacy and safety of the novel surgical strategy To assess the efficacy and safety of the novel surgical strategy, all included patients were divided into two groups according to the timing of receiving treatment: 1) the early period group: patients admitted before January 2021 received the hybrid strategy of traditional and novel surgical strategies; and 2) the late period group: patients admitted during and after January 2021 received the complete novel surgical strategy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive patients older than 18 years with necrotizing pancreatitis were included.

排除标准

  • Patients who met one or more of the following criteria were excluded: (1) had a past medical history of acute pancreatitis; (2) had drainage or surgery for pancreatic necrosis in other hospitals before admission to our institute; and (3) did not complete the treatment strategy owing to nonmedical reasons.

结局指标

主要结局

major complications

时间窗: 90-day follow up

次要结局

  • Admission of ICU(up to 90-days)
  • mortality(90-day follow up)
  • individual major complications(90-day follow up)
  • Length of hospital stay(up to 90-days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Yang

Resident physicians

Tianjin Nankai Hospital

研究点 (1)

Loading locations...

相似试验

A Novel Surgical Strategy to Reduce Major... | 临床试验